European breast cancer service screening outcomes: A first balance sheet of the benefits and harms

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 7, 2014, Pages 1159-1163

  Paci, Eugenio ^a   Broeders, Mireille ^b   Hofvind, Solveig ^c   Puliti, Donella ^a   Duffy, Stephen William ^d  

^a ISPO Cancer Prevention and Research Institute ^*  (Italy)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c OSLO METROPOLITAN UNIVERSITY   (Norway)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BALANCE SHEET; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CAUSE OF DEATH; CLINICAL ASSESSMENT TOOL; DECISION MAKING; FALSE POSITIVE RESULT; FOLLOW UP; HUMAN; INVASIVE PROCEDURE; MAMMOGRAPHY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POPULATION; PRIORITY JOURNAL; REVIEW; RISK REDUCTION;

EID: 84903995638     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0320     Document Type: Review

References (15)

1. Wald N, Frost C, Cuckle H. Breast cancer screening: the current position. BMJ 1991;302: 845-6.
2. von Karsa L, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, et al. Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening-First report. European Commission: Luxembourg; 2008.
3. Giordano L, von Karsa L, Tomatis M, Majek O, de Wolf C, Lancucki L, et al. Mammographic screening programmes in Europe: organisation, coverage and participation. JMed Screening 2012;19 (Suppl 1): 72-82.
4. European Commission. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th edition.PerryN, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L editors. Office for Official Publications of the European Communities: Luxembourg; 2006.
5. Moss SM, Nystrom L, Jonsson H, Paci E, Lynge E, Njor S, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies. J Med screen 2012;19 (Suppl 1): 26-2.
6. Njor S, Nystrom L, Moss S, Paci E, Broeders M, SegnanN, et al. Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med screen 2012;19 (Suppl 1): 33-1.
7. Broeders M, Moss S, Nystrom L, Njor S, Jonsson H, Paap E, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen 2012;19 (Suppl 1): 14-5.
8. Paap E, Verbeek ALM, Puliti D, Paci E, Broeders MJ. Breast cancer screening case-control study design: impact on breast cancer mortality. Ann Oncol 2011;22: 863-9.
9. Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med screen 2012;19 (Suppl 1): 42-6.
10. Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, et al. False positive results in mammographic screening for breast cancer in Europe: a literature review and surveys of service screening programmes. J Med screen 2012;19 (Suppl 1): 57-66.
11. Paci E, Duffy S. Overdiagnosis and overtreatment of breast cancer: overdiagnosis and overtreatment in service screening. Breast Cancer Res 2005;7: 266-70.
12. Harris R, Sawaya GF, Moyer VA, Calonge N. Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive services task force. Epidemiol Rev 2011;33: 20-5.
13. IARC Handbooks of Cancer Prevention. Breast cancer screening. Vol 7. Lyon, France: IARC;2002.
14. Giordano L, Cogo C, Patnick J, Paci E and the EUROSCREEN Working Group. Communicating the balance sheet in breast cancer screening. J Med Screen 2012;19 (Suppl 1): 67-71.
15. Independent UK Panel on breast cancer screening. The Benefits and harms of breast cancer screening: an independent review. Lancet 2012;380: 1778-86.